For the Inventor, By the Inventor

Enter assignee name

Mississauga, Canada

Hyal Pharmaceutical Corporation

USPTO Granted Patents = 41

Forward Citations = 699

Loading Chart...

Loading Chart...

16 inventors (with patents filed for the assignee):

Samuel Simon Asculai (36 out of 38 patents)

Rudolf Edgar Falk (30 out of 33 patents)

Ehud Shmuel Klein (11 out of 11 patents)

4. David William Harper (11 out of 11 patents)

5. David Hochman (10 out of 10 patents)

6. Don Purschke (10 out of 10 patents)

7. Rudolf Edger Falk (6 out of 6 patents)

8. Eva Anne Turley (5 out of 11 patents)

9. Alan Drizen (3 out of 4 patents)

10. Anthony E Bolton (1 out of 17 patents)

11. Samuel Simon Ascuali (1 out of 2 patents)

12. Chandan Alam (1 out of 2 patents)

13. Derek A Willoughby (1 out of 3 patents)

14. Anita Aviad (1 out of 1 patent)

15. Stefan Gustafson (1 out of 1 patent)

Core Competencies:

Hyaluronic Acid

Therapeutic Methods

Topical Composition

Drug Delivery

NSAIDs

Arterial Restenosis

Atherosclerosis

Immune Cell Proliferation

Ischemia Reperfusion

Macrophage Treatment

Equine Navicular Disease

41 patents: Sort by Forward Citations

1. 6218373 - Formulations containing hyaluronic acid (2001-04-17),

2. 6194392 - Treatment of conditions and disease (2001-02-27),

3. 6147059 - Formulations containing hyaluronic acid (2000-11-14),

4. 6140312 - Formulations containing hyaluronic acid (2000-10-31),

5. 6136793 - Formulations containing hyaluronic acid (2000-10-24),

6. 6114314 - Formulations containing hyaluronic acid (2000-09-05),

7. 6103704 - Therapeutic methods using hyaluronic acid (2000-08-15),

8. 6087344 - Formulations containing hyaluronic acid (2000-07-11),

9. 6069135 - Use of hyaluronic acid or its derivatives to enhance delivery of (2000-05-30),

10. 6048844 - Treatment of conditions and disease (2000-04-11),

11. 6022866 - Use of hyaluronic acid and forms to prevent arterial restenosis (2000-02-08),

12. 6017900 - Topical composition containing hyaluronic acid and nsaids (2000-01-25),

13. 5990096 - Formulations containing hyaluronic acid (1999-11-23),

14. 5990095 - Use of hyaluronic acid and forms to prevent arterial restenosis (1999-11-23),

15. 5985851 - Use of hyaluronic acid or its derivatives in peritoneal dialysis and (1999-11-16),

Hyal Pharmaceutical Corporation, based in Mississauga, Canada, specializes in the development and manufacturing of innovative therapeutic solutions utilizing hyaluronic acid. The company focuses on advanced topical compositions and therapeutic methods aimed at addressing conditions such as arterial restenosis and ischemia reperfusion injury. Their research encompasses angiogenesis inhibition and macrophage treatment, positioning them at the forefront of medical advancements in regenerative medicine and pain management.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

41 Patents

#24 in Mississauga

#337 in Canada

#16,669 in the World

Mississauga, Canada

Hyal Pharmaceutical Corporation

Forward Citations = 699

16 inventors:

Samuel Simon Asculai (36 out of 38 patents)

Rudolf Edgar Falk (30 out of 33 patents)

Ehud Shmuel Klein (11 out of 11 patents)

4. David William Harper (11 out of 11 patents)

5. David Hochman (10 out of 10 patents)

Please report any incorrect information to [email protected]

Loading…